The Three‐Dimensional Structure of the N‐Terminal Domain of Corticotropin‐Releasing Factor Receptors Sushi Domains and the B1 Family of G Protein–Coupled Receptors
The corticotropin‐releasing factor (CRF) receptors, CRF‐R1 and CRF‐R2, belong to the B1 subfamily of G protein–coupled Receptors (GPCRs), including receptors for secretin, growth hormone‐releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase‐activating polypeptide...
Saved in:
Published in | Annals of the New York Academy of Sciences Vol. 1070; no. 1; pp. 105 - 119 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.07.2006
|
Subjects | |
Online Access | Get full text |
ISSN | 0077-8923 1749-6632 |
DOI | 10.1196/annals.1317.065 |
Cover
Abstract | The corticotropin‐releasing factor (CRF) receptors, CRF‐R1 and CRF‐R2, belong to the B1 subfamily of G protein–coupled Receptors (GPCRs), including receptors for secretin, growth hormone‐releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase‐activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon‐like peptide‐1 (GLP‐1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF‐R1 has higher affinity for CRF than does CRF‐R2 while both receptors bind Ucn 1 equally. CRF‐R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus/first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three‐dimentional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF‐R2β (
1
) identified its structural fold as a Sushi domain/short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65–Arg101)
. Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well‐defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full‐length receptor reduces its affinity for CRF ligands. A structure‐based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s. |
---|---|
AbstractList | The corticotropin‐releasing factor (CRF) receptors, CRF‐R1 and CRF‐R2, belong to the B1 subfamily of G protein–coupled Receptors (GPCRs), including receptors for secretin, growth hormone‐releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase‐activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon‐like peptide‐1 (GLP‐1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF‐R1 has higher affinity for CRF than does CRF‐R2 while both receptors bind Ucn 1 equally. CRF‐R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus/first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three‐dimentional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF‐R2β (
1
) identified its structural fold as a Sushi domain/short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65–Arg101)
. Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well‐defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full‐length receptor reduces its affinity for CRF ligands. A structure‐based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s. The corticotropin-releasing factor (CRF) receptors, CRF-R1 and CRF-R2, belong to the B1 subfamily of G protein-coupled Receptors (GPCRs), including receptors for secretin, growth hormone-releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon-like peptide-1 (GLP-1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF-R1 has higher affinity for CRF than does CRF-R2 while both receptors bind Ucn 1 equally. CRF-R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus/first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three-dimentional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF-R2 beta (1) identified its structural fold as a Sushi domain/short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65-Arg101). Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well-defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full-length receptor reduces its affinity for CRF ligands. A structure-based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s. The corticotropin-releasing factor (CRF) receptors, CRF-R1 and CRF-R2, belong to the B1 subfamily of G protein-coupled Receptors (GPCRs), including receptors for secretin, growth hormone-releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon-like peptide-1 (GLP-1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF-R1 has higher affinity for CRF than does CRF-R2 while both receptors bind Ucn 1 equally. CRF-R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus-first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three-dimentional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF-R2b (1) identified its structural fold as a Sushi domain-short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65-Arg101). Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well-defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full-length receptor reduces its affinity for CRF ligands. A structure-based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s. The corticotropin-releasing factor (CRF) receptors, CRF-R1 and CRF-R2, belong to the B1 subfamily of G protein-coupled Receptors (GPCRs), including receptors for secretin, growth hormone-releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon-like peptide-1 (GLP-1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF-R1 has higher affinity for CRF than does CRF-R2 while both receptors bind Ucn 1 equally. CRF-R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus/first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three-dimensional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF-R2beta (1) identified its structural fold as a Sushi domain/short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65-Arg101). Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well-defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full-length receptor reduces its affinity for CRF ligands. A structure-based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s. The corticotropin-releasing factor (CRF) receptors, CRF-R1 and CRF-R2, belong to the B1 subfamily of G protein-coupled Receptors (GPCRs), including receptors for secretin, growth hormone-releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon-like peptide-1 (GLP-1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF-R1 has higher affinity for CRF than does CRF-R2 while both receptors bind Ucn 1 equally. CRF-R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus/first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three-dimensional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF-R2beta (1) identified its structural fold as a Sushi domain/short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65-Arg101). Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well-defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full-length receptor reduces its affinity for CRF ligands. A structure-based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s.The corticotropin-releasing factor (CRF) receptors, CRF-R1 and CRF-R2, belong to the B1 subfamily of G protein-coupled Receptors (GPCRs), including receptors for secretin, growth hormone-releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon-like peptide-1 (GLP-1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF-R1 has higher affinity for CRF than does CRF-R2 while both receptors bind Ucn 1 equally. CRF-R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus/first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three-dimensional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF-R2beta (1) identified its structural fold as a Sushi domain/short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65-Arg101). Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well-defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full-length receptor reduces its affinity for CRF ligands. A structure-based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s. |
Author | RIEK, ROLAND GRACE, CHRISTY R. R. VALE, WYLIE W. PERRIN, MARILYN H. |
Author_xml | – sequence: 1 givenname: MARILYN H. surname: PERRIN fullname: PERRIN, MARILYN H. – sequence: 2 givenname: CHRISTY R. R. surname: GRACE fullname: GRACE, CHRISTY R. R. – sequence: 3 givenname: ROLAND surname: RIEK fullname: RIEK, ROLAND – sequence: 4 givenname: WYLIE W. surname: VALE fullname: VALE, WYLIE W. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16888152$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkU1LXDEUhkOx1PFj7U7uqrs75uPmaylj1YJY0HF9ycSTGrk3mSa5i-76E_ob_SVmGItQEF2dwHnel0OePbQTYgCEjgieE6LFiQnBDHlOGJFzLPgnNCOy060QjO6gGcZStkpTtov2cn7EmFDVyS9olwilFOF0hh6XD9AsHxLA05-_Z36EkH2snc1tSZMtU4ImuqZU6LoCS0ij32zP4mh82KwWMRVvY0lx7UNFbmAAk3342ZwbW2JqbsDCuj7yAfrs6rFw-DL30d35t-Xisr36cfF9cXrVWsZlaTkH7e6JoYRLQRzmTjhlVoKZleowc53ujGXAuNMdp0aAcAYktYZKqrRSbB993fauU_w1QS796LOFYTAB4pR7oSShtfpdkGgmtOq6D4GcKF7B4xdwWo1w36-TH0363f_77wqcbAGbYs4J3CuC-43Rfmu03xjtq9Ga4P8lrC-mVEklGT-8mXsGbq-qIA |
CitedBy_id | crossref_primary_10_1007_s00441_012_1450_4 crossref_primary_10_1016_j_ejphar_2010_01_027 crossref_primary_10_1007_s42000_018_0009_5 crossref_primary_10_1016_j_aanat_2016_05_004 crossref_primary_10_1146_annurev_pharmtox_48_113006_094630 crossref_primary_10_1002_ajmg_b_32046 crossref_primary_10_1016_j_ejphar_2024_176754 crossref_primary_10_1074_jbc_M806351200 crossref_primary_10_1523_JNEUROSCI_3172_09_2010 crossref_primary_10_1111_ahe_12094 crossref_primary_10_1021_jm300864p crossref_primary_10_1111_ahe_12110 crossref_primary_10_1016_j_intimp_2021_107872 crossref_primary_10_1111_j_1365_2982_2009_01412_x crossref_primary_10_1111_rda_13443 crossref_primary_10_1016_j_peptides_2010_01_004 crossref_primary_10_1152_physrev_00042_2017 crossref_primary_10_1124_pr_114_009464 crossref_primary_10_1155_2012_470851 crossref_primary_10_1177_1559325819860018 crossref_primary_10_6061_clinics_2017_09_09 crossref_primary_10_1016_j_repbio_2014_01_007 crossref_primary_10_1007_s00429_024_02879_0 crossref_primary_10_1002_ajmg_b_32115 crossref_primary_10_1210_er_2012_1092 crossref_primary_10_1124_mol_110_065474 crossref_primary_10_1002_cne_21848 crossref_primary_10_1002_jcp_21632 crossref_primary_10_1016_j_ygcen_2011_04_004 crossref_primary_10_1021_jm300259r crossref_primary_10_1016_j_bmcl_2011_02_086 crossref_primary_10_1038_s41467_022_33851_3 |
Cites_doi | 10.1073/pnas.92.7.2969 10.1074/jbc.M001596200 10.1074/jbc.M101770200 10.1124/mol.61.5.1132 10.1016/S0014-5793(96)01214-8 10.1073/pnas.92.4.1108 10.1093/intimm/12.4.439 10.1210/me.9.5.637 10.1016/S0301-4622(02)00005-4 10.1073/pnas.92.23.10575 10.1210/en.2002-0087 10.1111/j.1432-1033.2004.04216.x 10.1074/jbc.M406540200 10.1210/mend.11.13.0034 10.1038/364208a0 10.1074/jbc.273.9.4990 10.1073/pnas.0409583102 10.1093/emboj/18.22.6228 10.1046/j.1471-4159.1999.0720388.x 10.1073/pnas.051626398 10.1126/science.6267699 10.1038/87936 10.1073/pnas.90.19.8967 10.1046/j.1432-1327.1999.00007.x 10.1073/pnas.121165198 10.1074/jbc.M101838200 10.1073/pnas.0307200101 10.1021/jm034180 10.1146/annurev.pharmtox.44.101802.121410 10.1016/S0014-2999(99)00915-2 10.1016/S0028-3908(98)00201-9 10.1021/bi0001426 10.1046/j.1471-4159.1999.0730821.x 10.1210/me.12.8.1077 10.1016/S0196-9781(99)00122-9 10.1074/jbc.275.12.8508 10.1073/pnas.0404702101 10.1016/0896-6273(93)90230-O 10.1016/0014-5793(93)80427-V 10.1017/S0033583500005783 10.1038/nrm1130 10.1016/j.bbrc.2004.05.103 10.1084/jem.184.3.1185 10.1124/pr.55.1.3 10.1073/pnas.92.3.836 10.1073/pnas.97.18.10277 10.1038/349423a0 10.1016/S1359-6446(05)03370-2 10.1110/ps.12101 10.1021/bi036110a 10.1016/S0028-3908(00)00105-2 10.1002/cbic.200300769 10.1038/378287a0 10.1074/jbc.M210476200 10.1210/endo.139.2.5757 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7ST 7U6 C1K 7X8 |
DOI | 10.1196/annals.1317.065 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Environment Abstracts Sustainability Science Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Environment Abstracts Sustainability Science Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef Environment Abstracts Environment Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) Biology |
EISSN | 1749-6632 |
EndPage | 119 |
ExternalDocumentID | 16888152 10_1196_annals_1317_065 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: P01 DK26741 |
GroupedDBID | --- --Z -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1CY 1OB 1OC 23M 31~ 33P 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 692 6J9 702 79B 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAYXX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACIWK ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADXHL ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AELAQ AENEX AEQDE AEUYR AEYWJ AFBPY AFFNX AFFPM AFGKR AFRAH AFSWV AFWVQ AFZJQ AGHNM AGQPQ AGYGG AHBTC AHDLI AHEFC AHMBA AI. AIAGR AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AUFTA AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BIYOS BMNLL BMXJE BNHUX BROTX BRXPI BY8 C45 CAG CITATION CO8 COF CS3 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRSTM EBD EBS EJD EMOBN ESX F00 F01 F04 F5P FEDTE FZ0 G-S G.N GODZA H.T H.X HF~ HGLYW HVGLF HZI HZ~ I-F IH2 IX1 J0M K48 L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NHB O66 O9- OHT OIG OK1 OVD P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 R.K RAG RIWAO RJQFR ROL RX1 S10 SAMSI SJN SUPJJ SV3 TEORI TUS UB1 UPT V8K VH1 W8V W99 WBKPD WH7 WHWMO WIH WIK WOHZO WQJ WVDHM WXSBR X7M XG1 YBU YOC YSK ZGI ZKB ZXP ZZTAW ~02 ~IA ~KM ~WT AAMDK AEUQT AFPWT CGR CUY CVF ECM EIF NPM WRC WUP 7ST 7U6 AAMMB AEFGJ AGXDD AIDQK AIDYY C1K 7X8 |
ID | FETCH-LOGICAL-c357t-55e9fd1a215761f05f6f8ab63ab8403f494ac3e35f9452a6e6fae72ca27289883 |
ISSN | 0077-8923 |
IngestDate | Fri Jul 11 12:13:02 EDT 2025 Fri Jul 11 07:52:17 EDT 2025 Fri Jul 11 11:43:32 EDT 2025 Wed Feb 19 01:52:59 EST 2025 Tue Jul 01 01:28:51 EDT 2025 Thu Apr 24 23:02:59 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c357t-55e9fd1a215761f05f6f8ab63ab8403f494ac3e35f9452a6e6fae72ca27289883 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 16888152 |
PQID | 19365185 |
PQPubID | 23462 |
PageCount | 15 |
ParticipantIDs | proquest_miscellaneous_68712761 proquest_miscellaneous_19369844 proquest_miscellaneous_19365185 pubmed_primary_16888152 crossref_primary_10_1196_annals_1317_065 crossref_citationtrail_10_1196_annals_1317_065 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2006-Jul |
PublicationDateYYYYMMDD | 2006-07-01 |
PublicationDate_xml | – month: 07 year: 2006 text: 2006-Jul |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Annals of the New York Academy of Sciences |
PublicationTitleAlternate | Ann N Y Acad Sci |
PublicationYear | 2006 |
References | e_1_2_4_40_2 Liaw C.W. (e_1_2_4_30_2) 1997; 11 e_1_2_4_44_2 e_1_2_4_21_2 e_1_2_4_42_2 e_1_2_4_23_2 e_1_2_4_48_2 e_1_2_4_25_2 e_1_2_4_46_2 e_1_2_4_27_2 e_1_2_4_29_2 e_1_2_4_3_2 Perrin M.H. (e_1_2_4_35_2) 1998; 139 e_1_2_4_5_2 e_1_2_4_7_2 e_1_2_4_50_2 e_1_2_4_9_2 e_1_2_4_31_2 e_1_2_4_54_2 e_1_2_4_10_2 e_1_2_4_33_2 e_1_2_4_52_2 e_1_2_4_12_2 e_1_2_4_14_2 e_1_2_4_37_2 e_1_2_4_56_2 e_1_2_4_39_2 e_1_2_4_16_2 e_1_2_4_18_2 e_1_2_4_20_2 e_1_2_4_43_2 e_1_2_4_22_2 e_1_2_4_41_2 e_1_2_4_24_2 e_1_2_4_47_2 e_1_2_4_26_2 e_1_2_4_45_2 e_1_2_4_28_2 e_1_2_4_49_2 e_1_2_4_2_2 e_1_2_4_4_2 e_1_2_4_6_2 e_1_2_4_8_2 e_1_2_4_51_2 e_1_2_4_55_2 e_1_2_4_11_2 e_1_2_4_32_2 e_1_2_4_53_2 e_1_2_4_13_2 e_1_2_4_34_2 e_1_2_4_15_2 e_1_2_4_36_2 e_1_2_4_17_2 e_1_2_4_38_2 e_1_2_4_19_2 |
References_xml | – ident: e_1_2_4_11_2 doi: 10.1073/pnas.92.7.2969 – ident: e_1_2_4_28_2 doi: 10.1074/jbc.M001596200 – ident: e_1_2_4_52_2 doi: 10.1074/jbc.M101770200 – ident: e_1_2_4_33_2 doi: 10.1124/mol.61.5.1132 – ident: e_1_2_4_42_2 doi: 10.1016/S0014-5793(96)01214-8 – ident: e_1_2_4_12_2 doi: 10.1073/pnas.92.4.1108 – ident: e_1_2_4_53_2 doi: 10.1093/intimm/12.4.439 – ident: e_1_2_4_13_2 doi: 10.1210/me.9.5.637 – ident: e_1_2_4_29_2 doi: 10.1016/S0301-4622(02)00005-4 – ident: e_1_2_4_23_2 doi: 10.1073/pnas.92.23.10575 – ident: e_1_2_4_22_2 doi: 10.1210/en.2002-0087 – ident: e_1_2_4_14_2 doi: 10.1111/j.1432-1033.2004.04216.x – ident: e_1_2_4_55_2 doi: 10.1074/jbc.M406540200 – volume: 11 start-page: 2048 year: 1997 ident: e_1_2_4_30_2 publication-title: Mol. Endocrinol. doi: 10.1210/mend.11.13.0034 – ident: e_1_2_4_47_2 doi: 10.1038/364208a0 – ident: e_1_2_4_50_2 doi: 10.1074/jbc.273.9.4990 – ident: e_1_2_4_18_2 doi: 10.1073/pnas.0409583102 – ident: e_1_2_4_46_2 doi: 10.1093/emboj/18.22.6228 – ident: e_1_2_4_37_2 doi: 10.1046/j.1471-4159.1999.0720388.x – ident: e_1_2_4_4_2 doi: 10.1073/pnas.051626398 – ident: e_1_2_4_2_2 doi: 10.1126/science.6267699 – ident: e_1_2_4_6_2 doi: 10.1038/87936 – ident: e_1_2_4_7_2 doi: 10.1073/pnas.90.19.8967 – ident: e_1_2_4_32_2 doi: 10.1046/j.1432-1327.1999.00007.x – ident: e_1_2_4_5_2 doi: 10.1073/pnas.121165198 – ident: e_1_2_4_38_2 doi: 10.1074/jbc.M101838200 – ident: e_1_2_4_54_2 doi: 10.1073/pnas.0307200101 – ident: e_1_2_4_26_2 doi: 10.1021/jm034180 – ident: e_1_2_4_20_2 doi: 10.1146/annurev.pharmtox.44.101802.121410 – ident: e_1_2_4_34_2 doi: 10.1016/S0014-2999(99)00915-2 – ident: e_1_2_4_15_2 doi: 10.1016/S0028-3908(98)00201-9 – ident: e_1_2_4_41_2 doi: 10.1021/bi0001426 – ident: e_1_2_4_31_2 doi: 10.1046/j.1471-4159.1999.0730821.x – ident: e_1_2_4_16_2 doi: 10.1210/me.12.8.1077 – ident: e_1_2_4_49_2 doi: 10.1016/S0196-9781(99)00122-9 – ident: e_1_2_4_21_2 doi: 10.1074/jbc.275.12.8508 – ident: e_1_2_4_44_2 doi: 10.1073/pnas.0404702101 – ident: e_1_2_4_9_2 doi: 10.1016/0896-6273(93)90230-O – ident: e_1_2_4_8_2 doi: 10.1016/0014-5793(93)80427-V – ident: e_1_2_4_45_2 doi: 10.1017/S0033583500005783 – ident: e_1_2_4_56_2 doi: 10.1038/nrm1130 – ident: e_1_2_4_48_2 doi: 10.1016/j.bbrc.2004.05.103 – ident: e_1_2_4_51_2 doi: 10.1084/jem.184.3.1185 – ident: e_1_2_4_19_2 doi: 10.1124/pr.55.1.3 – ident: e_1_2_4_10_2 doi: 10.1073/pnas.92.3.836 – ident: e_1_2_4_27_2 doi: 10.1073/pnas.97.18.10277 – ident: e_1_2_4_17_2 doi: 10.1038/349423a0 – ident: e_1_2_4_43_2 doi: 10.1016/S1359-6446(05)03370-2 – ident: e_1_2_4_39_2 doi: 10.1110/ps.12101 – ident: e_1_2_4_36_2 doi: 10.1021/bi036110a – ident: e_1_2_4_24_2 doi: 10.1016/S0028-3908(00)00105-2 – ident: e_1_2_4_25_2 doi: 10.1002/cbic.200300769 – ident: e_1_2_4_3_2 doi: 10.1038/378287a0 – ident: e_1_2_4_40_2 doi: 10.1074/jbc.M210476200 – volume: 139 start-page: 566 year: 1998 ident: e_1_2_4_35_2 publication-title: Endocrinology doi: 10.1210/endo.139.2.5757 |
SSID | ssj0012847 |
Score | 2.0478585 |
Snippet | The corticotropin‐releasing factor (CRF) receptors, CRF‐R1 and CRF‐R2, belong to the B1 subfamily of G protein–coupled Receptors (GPCRs), including receptors... The corticotropin-releasing factor (CRF) receptors, CRF-R1 and CRF-R2, belong to the B1 subfamily of G protein-coupled Receptors (GPCRs), including receptors... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 105 |
SubjectTerms | Animals Humans Ligands Models, Molecular Mutation - genetics Protein Conformation Receptors, Corticotropin-Releasing Hormone - chemistry Receptors, Corticotropin-Releasing Hormone - classification Receptors, Corticotropin-Releasing Hormone - genetics Receptors, Corticotropin-Releasing Hormone - metabolism |
Subtitle | Sushi Domains and the B1 Family of G Protein–Coupled Receptors |
Title | The Three‐Dimensional Structure of the N‐Terminal Domain of Corticotropin‐Releasing Factor Receptors |
URI | https://www.ncbi.nlm.nih.gov/pubmed/16888152 https://www.proquest.com/docview/19365185 https://www.proquest.com/docview/19369844 https://www.proquest.com/docview/68712761 |
Volume | 1070 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECXcFAV6KZp0c1ceekhhyNVCSmRvSZE4KBIXCGzUN4GSSNSoKxleDu639NgP7XCR5KRxt4tgSORYxnsmh-TMG4ReZzSnLFHEE0WWeUQm3OOwsvAKneBTEEXyWGcjXwzjszH5MKGTTuf7VtTSepX182835pX8D6pwD3DVWbL_gGxjFG7AZ8AXroAwXP8a4xWAIb1Ci_RbgY2elYTVBwPu_H_ouZCXWa-ovoppaWPJtb1qtdAZU54unSLMtoEtwNODgVDOdSUevWWwXC8_T13fZRNzeRzU2yNgbtAzig9gKq_W85ksWgvb_m-r11wHVxrNqKM2r8UNNst2zF4srM7BBSzrZ5uyTacYLNwRgFVIgNVEG_54OZVfbOS4q1HiyorZ6OlPG3C9bWzh9pZHUm95uGE8gamV20TlZhj3bQUSNxIHJpv7hhmCO2lk-LX9ALynvm-LVVzV4h5-TE_H5-fp6GQyuoVuhwl4ZtrlvmzEyczEbuZ59zJOOAq-4O0181d9nh0LGePQjO6je24lgo8srfZRR5YH6I6tTbo5QPs1EPjQSZO_eYB-AOPwL4zDDeNwpeCxxC3jsGWNfrCDcdgyDjd8eYcN31zPJQb8jNHjAFu-aWMDfI1vbf-HaHx6Mnp_5rk6H14e0WTlUSq5KgIB3mcSB8qnKlZMZHEkMkb8SBFORB7JiCpOaChiGSshkzAXYRIyzlj0CO2VVSmfIOwnUtBAiEj6jFChBLQIAy2BJMMoj0UX9Wsk0tyJ4OtaLLPULIa5SdAH6FINXQrQddFh02Fu9V92N31VQ5vCGK0P3kQpqzW04FFMwTH-fQvOCNndImZJACwMuuixZU37OjFjDNzwp3_s-wzdbf9Oz9EekEO-AJ96lb001P4J2lHWgQ |
linkProvider | Wiley-Blackwell |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+three-dimensional+structure+of+the+N-terminal+domain+of+corticotropin-releasing+factor+receptors%3A+sushi+domains+and+the+B1+family+of+G+protein-coupled+receptors&rft.jtitle=Annals+of+the+New+York+Academy+of+Sciences&rft.au=Perrin%2C+Marilyn+H&rft.au=Grace%2C+Christy+R+R&rft.au=Riek%2C+Roland&rft.au=Vale%2C+Wylie+W&rft.date=2006-07-01&rft.issn=0077-8923&rft.volume=1070&rft.spage=105&rft_id=info:doi/10.1196%2Fannals.1317.065&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0077-8923&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0077-8923&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0077-8923&client=summon |